JPRN-UMIN000009067已完成1 期
Phase I trial of Gemcitabine plus nab-Paclitaxel for metastatic breast cancer - Phase I trial of Gemcitabine plus nab-Paclitaxel for metastatic breast cancer
Okayama Univesity Hospital0 个研究点目标入组 9 人开始时间: 2012年10月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Allergy of the Gemcitabine or nab-Paclitaxel 2)Contraindication to treatment with Gemcitabine or nab-Paclitaxel 3)With sever complications ex.)with incontrollable diabetes,with infection,mental disorder which become problem on clinical practice 4)During pregnancy or lactation 5)With extensive liver metastases, or lymphatic vessel-related metastases to lung with dyspnea 6)With active double cancer 7)With symptomatic brain cancer 8)HBs antigen is positive 9)With uncontrollable hypertension, angina, congestive heart failure, myocardial infection within 1 year, arrhythmia, valvular heart disease 10)With pulmonary fibrosis or pneumonitis 11)With dyspnea at rest 12)With uncontrolled pleural effusion, peritoneal effusion, pericardial effusion 13)With grade 2 or grater peripheral neuropathy 14)Patients judged by the investigator as unfit to be enrolled in the study
研究者
相似试验
已完成
1 期
Phase 1 trial of Nab-paclitaxel and Gemcitabine for metastatic breast cancerBreast cancerJPRN-UMIN000010125Tokyo-West Tokushukai Hospital6
进行中（未招募）
1 期
Phase I-II trial of gemcitabine plus nab-paclitaxel (GemBrax) followed by FOLFIRINOX as first-line treatment of patients with metastatic pancreatic adenocarcinoma - GABRINOXEUCTR2012-003678-13-FRInstitut Régional de Cancerologie de Montpellier - Val d’Aurelle118
已完成
2 期
Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerlocally advanced unresectable pancreatic cancerJPRN-UMIN000016852Kurume university school of medicine24
已完成
不适用
Phase I/II study of Gemcitabine plus nab-paclitaxel and intraperitoneal paclitaxel for pancreas cancer with peritoneal metastasisThe patients with pancreatic cancer who have peritoneal metastasis diagnosed by staging laparoscopy or open laparotomy.JPRN-UMIN000018878Study group of pancreatic cancer with peritoneal metastasis48
已完成
2 期
Phase II study of gemcitabine plus nab-Pacletaxel as second-line therapy after FOLFIRINOX for advanced pancreatic canceradvanced pancreatic cancerJPRN-UMIN000016624Gifu University Hospital30